Exciting news! STAT has moved its comment section to our subscriber-only app, STAT+ Connect. Subscribe to STAT+ today to join the conversation or join us on Twitter, Facebook, LinkedIn, and Threads. Let’s stay connected!
To submit a correction request, please visit our Contact Us page.
Fore Biotherapeutics has reeled in a $75 million Series D, and its CEO Matthew Ros is walking off the course for “other professional pursuits,” the
STAT Virtual Event | How to Increase Diversity in Clinical Trials: Strategies & Tools
Exciting news! STAT has moved its comment section to our subscriber-only app, STAT+ Connect. Subscribe to STAT+ today to join the conversation or join us on Twitter, Facebook, LinkedIn, and Threads. Let’s stay connected!
To submit a correction request, please visit our Contact Us page.
Sacklers call opioid-related fraud claims ‘utterly meritless’
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Fore scores $75M Series D, tees up new leadership with ex-Elevation CEO Shawn Leland at the helm — for now
Fore Biotherapeutics has reeled in a $75 million Series D, and its CEO Matthew Ros is walking off the course for “other professional pursuits,” the
What we know about H5N1 bird flu in cows — and the risk to humans
The discovery of H5N1 bird flu in U.S. cattle — and the news that at least one person in Texas has been infected, apparently through